≡ Risteys
R10

Documentation Changelog GitHub Contact & Feedback

Amyloidosis, other/unspecified

DOID EFO MESH SNOMED Endpoint Browser PheWeb

E4_AMYLNAS

amyloidosis: A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.

Endpoint definition

↥
FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 E85[8-9]
Hospital discharge: ICD-9 2773
Hospital discharge: ICD-8 27699
Cause of death: ICD-10 E85[8-9]
Cause of death: ICD-9 2773
Cause of death: ICD-8 27699

2 out of 7 registries used, show all original rules.

457

diagram downward connector

Check minimum number of events None

457

diagram downward connector

Include endpoints None

457

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

448

diagram downward connector
E4_AMYLNAS

Control definitions

Control exclude E4_METABOLIA

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 448 221 227
Unadjusted prevalence (%) 0.11 0.10 0.12
Mean age at first event (years) 63.20 59.48 66.82

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: E4_AMYLNAS – Amyloidosis, other/unspecified
GWS hits: 10

Survival analyses between endpoints

↥

Plot

before Amyloidosis, other/unspecified
after Amyloidosis, other/unspecified

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Amyloidosis, other/unspecified

↥

Endpoint not on priority list, no data to show.